These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24410456)

  • 1. Large-scale assessment of activity landscape feature probabilities of bioactive compounds.
    Kayastha S; Dimova D; Iyer P; Vogt M; Bajorath J
    J Chem Inf Model; 2014 Feb; 54(2):442-50. PubMed ID: 24410456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditional probabilities of activity landscape features for individual compounds.
    Vogt M; Iyer P; Maggiora GM; Bajorath J
    J Chem Inf Model; 2013 Jul; 53(7):1602-12. PubMed ID: 23789585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of an activity landscape view taking compound-based feature probabilities into account.
    Zhang B; Vogt M; Bajorath J
    J Comput Aided Mol Des; 2014 Sep; 28(9):919-26. PubMed ID: 25001923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationalizing three-dimensional activity landscapes and the influence of molecular representations on landscape topology and the formation of activity cliffs.
    Peltason L; Iyer P; Bajorath J
    J Chem Inf Model; 2010 Jun; 50(6):1021-33. PubMed ID: 20443603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of multitarget activity landscapes that capture hierarchical activity cliff distributions.
    Dimova D; Wawer M; Wassermann AM; Bajorath J
    J Chem Inf Model; 2011 Feb; 51(2):258-66. PubMed ID: 21275393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Representation of multi-target activity landscapes through target pair-based compound encoding in self-organizing maps.
    Iyer P; Bajorath J
    Chem Biol Drug Des; 2011 Nov; 78(5):778-86. PubMed ID: 21895984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From activity cliffs to activity ridges: informative data structures for SAR analysis.
    Vogt M; Huang Y; Bajorath J
    J Chem Inf Model; 2011 Aug; 51(8):1848-56. PubMed ID: 21761918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of individual compounds forming activity cliffs using emerging chemical patterns.
    Namasivayam V; Iyer P; Bajorath J
    J Chem Inf Model; 2013 Dec; 53(12):3131-9. PubMed ID: 24304008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioactivity landscape modeling: chemoinformatic characterization of structure-activity relationships of compounds tested across multiple targets.
    Waddell J; Medina-Franco JL
    Bioorg Med Chem; 2012 Sep; 20(18):5443-52. PubMed ID: 22178187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of single- and multi-target activity cliffs formed by currently available bioactive compounds.
    Wassermann AM; Dimova D; Bajorath J
    Chem Biol Drug Des; 2011 Aug; 78(2):224-8. PubMed ID: 21624090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Composition and topology of activity cliff clusters formed by bioactive compounds.
    Stumpfe D; Dimova D; Bajorath J
    J Chem Inf Model; 2014 Feb; 54(2):451-61. PubMed ID: 24437577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity cliff networks for medicinal chemistry.
    Stumpfe D; Bajorath J
    Drug Dev Res; 2014 Aug; 75(5):291-8. PubMed ID: 25160069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of a three-dimensional multitarget activity landscape.
    de la Vega de León A; Bajorath J
    J Chem Inf Model; 2012 Nov; 52(11):2876-83. PubMed ID: 23113585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploration of 3D activity cliffs on the basis of compound binding modes and comparison of 2D and 3D cliffs.
    Hu Y; Bajorath J
    J Chem Inf Model; 2012 Mar; 52(3):670-7. PubMed ID: 22394306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity Landscapes, Information Theory, and Structure - Activity Relationships.
    Iyer P; Stumpfe D; Vogt M; Bajorath J; Maggiora GM
    Mol Inform; 2013 Jun; 32(5-6):421-30. PubMed ID: 27481663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity landscape of DNA methyltransferase inhibitors bridges chemoinformatics with epigenetic drug discovery.
    Naveja JJ; Medina-Franco JL
    Expert Opin Drug Discov; 2015 Oct; 10(10):1059-70. PubMed ID: 26289576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multitarget structure-activity relationships characterized by activity-difference maps and consensus similarity measure.
    Medina-Franco JL; Yongye AB; Pérez-Villanueva J; Houghten RA; Martínez-Mayorga K
    J Chem Inf Model; 2011 Sep; 51(9):2427-39. PubMed ID: 21842860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular scaffolds with high propensity to form multi-target activity cliffs.
    Hu Y; Bajorath J
    J Chem Inf Model; 2010 Apr; 50(4):500-10. PubMed ID: 20361784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity cliffs: facts or artifacts?
    Medina-Franco JL
    Chem Biol Drug Des; 2013 May; 81(5):553-6. PubMed ID: 23375049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From structure-activity to structure-selectivity relationships: quantitative assessment, selectivity cliffs, and key compounds.
    Peltason L; Hu Y; Bajorath J
    ChemMedChem; 2009 Nov; 4(11):1864-73. PubMed ID: 19750525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.